Global Cell Viability Assays Market to Reach $2.58 Billion by 2029, Growing at 10.5% CAGR

"How Are the key drivers contributing to the expansion of the cell viability assays market?
The rise in cell-based therapeutics is anticipated to boost the expansion of the cell viability assay market. These therapeutics, which utilize live cells to repair damaged tissues, counter diseases, or regain regular operations, are fueled by biotechnological advancements, a growing focus on regenerative medicine, a widespread acceptance and uptake of cell therapies, and enhancements in cell engineering and manufacturing technologies. Cell viability assays play an essential role in cellular therapies by ascertaining the health, function, and safety of therapeutic cells, thus enhancing treatment effectiveness and quality control. For example, the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, reported that 38 trials were initiated for non-genetically modified cell therapies in the first quarter of 2023, an increase of 7 from the last quarter of 2022. Hence, the surge in cell-based therapeutics is propelling the growth of the cell viability assay market.

Get Your Cell Viability Assays Market Report Here:
https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

What growth opportunities are expected to drive the cell viability assays market's CAGR through 2034?
The market for cell viability assays has experienced a significant expansion in the recent past. It is projected that it will expand from $1.56 billion in 2024 to reach a total value of $1.73 billion in 2025, with a compound annual growth rate (CAGR) of 10.8%. This noteworthy progression in the past years can be traced back to growing investment in oncology research, a rise in funds allocated to pharmaceutical research and development, an upward trajectory in the biotechnology industry, advancements in cell culture methodologies, a surge in the demand for stem cell research, a heightened need for toxicity testing, increased usage of real-time cellular analysis systems, and an upward trend in the count of contract research organizations (CROs).

The market size for cell viability assays is predicted to undergo accelerated growth in the upcoming years, reaching $2.58 billion in 2029 with a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this growth during the forecasted period include increasing demand for customised medicine, expanding governmental funding for cell-based research, a greater emphasis on precision medicine, advancements in stem cell research and application, better availability of automated cell viability analysers and an increase in infectious diseases. Other factors include increased attention to enhancing assay accuracy and sensitivity, rising awareness of the advantages of cell viability assays, growth in developing organ-on-chip technologies, and a surge in demand for regenerative medicine. Key trends to watch for during this period include advancements in high throughput screening approaches, the application of AI and machine learning algorithms, the creation of real-time monitoring systems, the use of automated liquid handling systems, the development of multiplex assays for concurrent cell viability measurement, the adoption of sustainable and environmentally friendly reagents, the creation of user-friendly assay kits, advancements in electrochemical assays, scalable cell viability assays, and the creation of assays that are compatible with primary and stem cells.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

What are the emerging trends shaping the future of the cell viability assays market?
Key players in the cell viability assays market are forging ahead with the development of pioneering cell screening technologies that will refine accuracy and boost the pace of drug discovery. Such technologies enrich cell viability assays by allowing a swift, exact, and high-volume assessment of cell health and responses, thereby fine-tuning experimental conditions and fostering the progression of healing strategies. As an illustration, Arralyze, a German tech firm launched a groundbreaking platform called CellShepherd for single-cell analysis in May 2024. This platform operates on proprietary nanowell glass arrays to downsize cell-based assays for real-time observation. This self-sufficient system provides accurate cell dispensing, sterile co-culturing, and brightfield and fluorescent channels imaging. With AI-powered analysis ensuring precise cell counting and tracking, this accessible platform meets the escalating requirement for detailed single-cell research in the fields of biomedicine and life sciences.

Which growth-oriented segments of the cell viability assays market are leading the industry's development?
The cell viability assays market covered in this report is segmented -

1) By Product: Consumables, Instruments
2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications
3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:
1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates
2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16014

North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the cell viability assays market?
Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

What Is Covered In The Cell Viability Assays Global Market Report?

•Market Size Forecast: Examine the cell viability assays market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the cell viability assays market for a structured understanding.
•Key Players Overview: Analyze major players in the cell viability assays market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the cell viability assays market.
•Segment Contributions: Evaluate how different segments drive overall growth in the cell viability assays market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the cell viability assays market.
•Industry Challenges: Identify potential risks and obstacles affecting the cell viability assays market.
•Competitive Landscape: Review strategic developments in the cell viability assays market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.